UN agency launches action plan against 'hidden' hepatitis

July 25, 2012

The World Health Organization (WHO) announced on Wednesday measures to fight the "hidden epidemic" of hepatitis which kills more than one million people a year.

The virus, which settles in the liver causing inflammation, affects 500 million people worldwide but can go unnoticed for years and even decades, the UN health agency told reporters in Geneva.

"The vast majority of people infected with hepatitis are unaware, undiagnosed and untreated," says Dr Sylvie Briand of WHO's Pandemic and Department.

"Only by increasing awareness of the different forms of hepatitis, and how they can be prevented and treated, can we take the first step towards full control of the disease and save thousands of lives," she added.

One in 12 people are infected by the virus which exists in five forms: A, B, C, D and E.

The WHO is particulary keen to target types B and C since "a high proportion" of people only become aware of their infection when they are chronically ill.

"This can sometimes be decades after infection," said Briand.

Launched ahead of World Hepatitis Day on July 28, the WHO's multi-pronged action plan to eradicate the virus calls on governments to raise awareness, transform research into policy and action, and prevent transmission by effective screening, care and treatment.

"It's a framework for global action so we all collaborate to fight the hidden epidemic", said Briand.

Individuals can protect themselves by washing their hands, food safety practices, practising and avoiding with infected needles, "one of the most common ways of getting infected in some countries", said Briand.

The virus was only discovered in 1989 but vaccines are available for all virus types except C.

A new generation of anti-viral treatments is also on offer for , said Briand, adding that other treatments to stop the B type developing into and cancer are also coming online.

Explore further: Hepatitis C kills more Americans than HIV: study

Related Stories

Hepatitis C kills more Americans than HIV: study

February 23, 2012
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.

CDC to baby boomers: Get tested for hepatitis C

May 18, 2012
(AP) -- For the first time, health officials are proposing that all baby boomers get tested for hepatitis C.

Egyptians design 'faster, cheaper' hepatitis C test

March 14, 2012
The American University in Cairo said Wednesday that a team of its researchers has designed a faster and cheaper test for all types of hepatitis C, which it says affects about 10 million Egyptians.

Recommended for you

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

Norovirus evades immune system by hiding out in rare gut cells

October 11, 2017
Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

Research reveals how rabies can induce frenzied behavior

October 11, 2017
Scientists may finally understand how the rabies virus can drastically change its host's behavior to help spread the disease, which kills about 59,000 people annually.

Experimental Ebola vaccines elicit year-long immune response

October 11, 2017
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.